Penumbra (PEN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $320.86, -0.11% vs the prior close of $321.20.
- Volume 278.51K shares, 0.9x its 50-day average.
- New SEC filings: 4 (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
PEN ends flat (-0.1%) to $320.86. Closed at $320.86, -0.11% vs the prior close of $321.20. Day range $320.15–$322.27, opened at $322.80.
PEN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PEN ends flat (-0.1%) to $320.86
- Closed at $320.86, -0.11% vs the prior close of $321.20. Day range $320.15–$322.27, opened at $322.80.
- Volume was 278.51K shares, 0.9x its 50-day average of 323.64K.
- Price is -0.1% vs its 50-day average ($321.14) and -1.9% vs its 200-day average ($327.05).
- 52-week range $221.26–$362.41; today's close sits at 71% of that range, 11.5% below the 52-week high.
Oct 15, 2026 — PEN rises 0.3% to $321.20, a 1-month high
- Closed at $321.20, +0.34% vs the prior close of $320.12. Day range $320.09–$322.17, opened at $322.13.
- Volume was 345.40K shares, 1.1x its 50-day average of 322.40K.
- Price is -0.0% vs its 50-day average ($321.22) and -1.8% vs its 200-day average ($327.02).
- 52-week range $221.26–$362.41; today's close sits at 71% of that range, 11.4% below the 52-week high.
Oct 14, 2026 — PEN ends flat (+0.0%) to $320.12
- Closed at $320.12, +0.03% vs the prior close of $320.01. Day range $319.25–$320.42, opened at $320.41.
- Volume was 272.30K shares, 0.8x its 50-day average of 324.21K.
- Price is -0.4% vs its 50-day average ($321.26) and -2.1% vs its 200-day average ($326.98).
- 52-week range $221.26–$362.41; today's close sits at 70% of that range, 11.7% below the 52-week high.
Oct 13, 2026 — PEN ends flat (-0.3%) to $320.01
- Closed at $320.01, -0.30% vs the prior close of $320.96. Day range $318.26–$320.99, opened at $320.93.
- Volume was 215.90K shares, 0.7x its 50-day average of 326.47K.
- Price is -0.4% vs its 50-day average ($321.34) and -2.1% vs its 200-day average ($326.97).
- 52-week range $221.26–$362.41; today's close sits at 70% of that range, 11.7% below the 52-week high.
Oct 12, 2026 — PEN rises 0.5% to $320.96, a 1-month high, 3 up days in a row
- Closed at $320.96, +0.49% vs the prior close of $319.40. Day range $318.97–$320.97, opened at $319.91.
- Volume was 277.20K shares, 0.8x its 50-day average of 326.84K.
- Price is -0.1% vs its 50-day average ($321.40) and -1.8% vs its 200-day average ($326.95).
- 52-week range $221.26–$362.41; today's close sits at 71% of that range, 11.4% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — PEN rises 0.6% to $319.40
- Closed at $319.40, +0.59% vs the prior close of $317.52. Day range $317.06–$319.53, opened at $317.06.
- Volume was 555.30K shares, 1.7x its 50-day average of 322.89K.
- Price is -0.6% vs its 50-day average ($321.40) and -2.3% vs its 200-day average ($326.92).
- 52-week range $221.26–$362.41; today's close sits at 70% of that range, 11.9% below the 52-week high.
Oct 8, 2026 — PEN rises 0.4% to $317.52
- Closed at $317.52, +0.37% vs the prior close of $316.35. Day range $316.53–$317.52, opened at $316.61.
- Volume was 379.40K shares, 1.2x its 50-day average of 322.61K.
- Price is -1.2% vs its 50-day average ($321.41) and -2.9% vs its 200-day average ($326.93).
- 52-week range $221.26–$362.41; today's close sits at 68% of that range, 12.4% below the 52-week high.
Oct 7, 2026 — PEN ends flat (-0.2%) to $316.35, a 1-month low, 7 down days in a row
- Closed at $316.35, -0.22% vs the prior close of $317.05. Day range $316.32–$317.74, opened at $316.62.
- Volume was 366.20K shares, 1.1x its 50-day average of 324.44K.
- Price is -1.6% vs its 50-day average ($321.46) and -3.2% vs its 200-day average ($326.92).
- 52-week range $221.26–$362.41; today's close sits at 67% of that range, 12.7% below the 52-week high.
- That makes 7 straight losses.
Oct 6, 2026 — PEN ends flat (-0.0%) to $317.05, a 1-month low, 6 down days in a row
- Closed at $317.05, -0.02% vs the prior close of $317.11. Day range $316.87–$318.01, opened at $317.10.
- Volume was 308.40K shares, 0.9x its 50-day average of 325.05K.
- Price is -1.4% vs its 50-day average ($321.54) and -3.0% vs its 200-day average ($326.92).
- 52-week range $221.26–$362.41; today's close sits at 68% of that range, 12.5% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — PEN ends flat (-0.1%) to $317.11, a 1-month low, 5 down days in a row
- Closed at $317.11, -0.14% vs the prior close of $317.55. Day range $317.10–$318.47, opened at $318.23.
- Volume was 368.30K shares, 1.1x its 50-day average of 324.98K.
- Price is -1.4% vs its 50-day average ($321.59) and -3.0% vs its 200-day average ($326.88).
- 52-week range $221.26–$362.41; today's close sits at 68% of that range, 12.5% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — PEN ends flat (-0.1%) to $317.55, a 1-month low, 4 down days in a row
- Closed at $317.55, -0.14% vs the prior close of $318.00. Day range $316.78–$318.37, opened at $318.37.
- Volume was 239.70K shares, 0.7x its 50-day average of 333.99K.
- Price is -1.3% vs its 50-day average ($321.62) and -2.8% vs its 200-day average ($326.83).
- 52-week range $221.26–$362.41; today's close sits at 68% of that range, 12.4% below the 52-week high.
- That makes 4 straight losses.
PEN latest news & SEC filings
Every SEC filing by or about PEN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Narayan Shruthi had withheld for taxes 1,367 shares at $321.20 (≈$439.08K) on Oct 15, 2026; now holds 31,283
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Narayan Shruthi had withheld for taxes 1,230 shares at $318.43 (≈$391.67K) on Sep 15, 2026; now holds 32,650
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $390.05M (prior year $339.45M) (+14.9% vs Jun 30, 2025)
- Net income: $34.81M (prior year $45.27M) (-23.1% vs Jun 30, 2025)
- Diluted EPS: $0.88 (prior year $1.15) (-23.5% vs Jun 30, 2025)
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade PEN
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 25, 2026, Jan 15, 2026. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.21% (largest 0.6%). That is a relatively calm stock.
- Liquidity: about 346.23K shares (≈$111.09M) trade per day on average.
- 52-week position: $320.86 vs a range of $221.26–$362.41 (71% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Harpreet Grewal sold 100 shares on Apr 2, 2026.
- Latest filings: 10-Q Jul 30, 2026; 8-K Jul 30, 2026; 8-K Jun 22, 2026.
- Share count: 39.39M shares outstanding (Jul 14, 2026), +1.0% vs a year earlier.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
PEN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 322.80 | 322.27 | 320.15 | 320.86 | 278.51K |
| Oct 15, 2026 | 322.13 | 322.17 | 320.09 | 321.20 | 345.40K |
| Oct 14, 2026 | 320.41 | 320.42 | 319.25 | 320.12 | 272.30K |
| Oct 13, 2026 | 320.93 | 320.99 | 318.26 | 320.01 | 215.90K |
| Oct 12, 2026 | 319.91 | 320.97 | 318.97 | 320.96 | 277.20K |
| Oct 9, 2026 | 317.06 | 319.53 | 317.06 | 319.40 | 555.30K |
| Oct 8, 2026 | 316.61 | 317.52 | 316.53 | 317.52 | 379.40K |
| Oct 7, 2026 | 316.62 | 317.74 | 316.32 | 316.35 | 366.20K |
| Oct 6, 2026 | 317.10 | 318.01 | 316.87 | 317.05 | 308.40K |
| Oct 5, 2026 | 318.23 | 318.47 | 317.10 | 317.11 | 368.30K |
| Oct 2, 2026 | 318.37 | 318.37 | 316.78 | 317.55 | 239.70K |
| Oct 1, 2026 | 318.38 | 318.92 | 317.92 | 318.00 | 350.40K |
| Sep 30, 2026 | 318.51 | 319.19 | 318.24 | 318.34 | 375.70K |
| Sep 29, 2026 | 318.73 | 318.98 | 318.14 | 318.86 | 189.80K |
| Sep 28, 2026 | 318.91 | 319.33 | 318.11 | 319.18 | 189.50K |
| Sep 25, 2026 | 319.28 | 319.61 | 318.17 | 318.89 | 228.10K |
| Sep 24, 2026 | 318.98 | 320.27 | 318.33 | 319.72 | 483.00K |
| Sep 23, 2026 | 319.46 | 320.26 | 318.40 | 319.44 | 410.60K |
| Sep 22, 2026 | 319.80 | 319.80 | 318.49 | 319.39 | 797.90K |
| Sep 21, 2026 | 317.38 | 318.78 | 316.77 | 318.78 | 292.90K |
About Penumbra
Penumbra (PEN) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in ALAMEDA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1321732.
PEN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Arani Bose | Director | Feb 18, 2026 |
| Adam Elsesser | CEO | May 21, 2026 |
| Harpreet Grewal | Director | Apr 6, 2026 |
| Janet Leeds | Director | Feb 18, 2026 |
| Bridget O'Rourke | Director | Feb 18, 2026 |
| Surbhi Sarna | Director | Feb 18, 2026 |
| Thomas Wilder | Director | Feb 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Adam Elsesser | CEO | May 21, 2026 |
| Shruthi Narayan | President | Sep 17, 2026 |
| Johanna Roberts | EVP, Gen. Counsel & Secretary | Mar 17, 2026 |
| Lambert Shiu | Chief Accounting Officer | Mar 17, 2026 |
| Maggie Yuen | Chief Financial Officer | Mar 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 2, 2026 | Harpreet Grewal | Sale | 100 | $328.22 |
| Apr 2, 2026 | Harpreet Grewal | Sale | 100 | $328.22 |
| Apr 2, 2026 | Harpreet Grewal | Sale | 100 | $328.22 |
| Apr 2, 2026 | Harpreet Grewal | Sale | 100 | $328.22 |
| Mar 2, 2026 | Maggie Yuen | Sale | 2,432 | $342.30 |
| Mar 2, 2026 | Maggie Yuen | Sale | 2,432 | $342.30 |
| Mar 2, 2026 | Maggie Yuen | Sale | 2,432 | $342.30 |
| Mar 2, 2026 | Maggie Yuen | Sale | 2,432 | $342.30 |
| Jan 6, 2026 | Harpreet Grewal | Sale | 186 | $312.64 |
| Jan 6, 2026 | Harpreet Grewal | Sale | 186 | $312.64 |
| Jan 6, 2026 | Harpreet Grewal | Sale | 186 | $312.64 |
| Jan 6, 2026 | Harpreet Grewal | Sale | 186 | $312.64 |
| Jan 2, 2026 | Thomas Wilder | Sale | 186 | $310.72 |
| Jan 2, 2026 | Thomas Wilder | Sale | 186 | $310.72 |
| Jan 2, 2026 | Thomas Wilder | Sale | 186 | $310.72 |
PEN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.40B | $177.69M | 4.52 | $238.66M |
| Dec 31, 2024 | $1.19B | $14.01M | 0.36 | $168.48M |
| Dec 31, 2023 | $1.06B | $90.95M | 2.32 | $97.33M |
| Dec 31, 2022 | $847.13M | $-2.00M | -0.05 | $-55.66M |
| Dec 31, 2021 | $747.59M | $5.28M | 0.14 | $9.50M |
Latest balance sheet: total assets $1.97B, total liabilities $443.96M, cash $205.27M (as of Jun 30, 2026).
PEN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $319.83 |
| May 6, 2026 | 8-K Item 2.02 (results) | $324.19 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $338.67 |
| Jan 15, 2026 | 8-K Item 2.02 (results) | $350.49 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $225.54 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $227.15 |
| Apr 23, 2025 | 8-K Item 2.02 (results) | $278.77 |
| Feb 18, 2025 | 8-K Item 2.02 (results) | $271.14 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $211.29 |
| Jul 30, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PEN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.